Yang YS, et al. - The effects of angiotensin receptor blockers (ARBs) on insulin secretion in hypertensive patients with type 2 diabetes were examined in this open-label, active comparator-controlled, crossover study. This research was conducted on 41 patients. It was observed that fimasartan increased late-phase glucose-stimulated insulin secretion in patients with type 2 diabetes and hypertension compared with amlodipine. The findings from the present study suggested that ARBs would be more advantageous in type 2 diabetic patients compared with other classes of anti-hypertensives.